These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10508196)

  • 1. Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells.
    Oram JF; Mendez AJ; Lymp J; Kavanagh TJ; Halbert CL
    J Lipid Res; 1999 Oct; 40(10):1769-81. PubMed ID: 10508196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux.
    Remaley AT; Schumacher UK; Stonik JA; Farsi BD; Nazih H; Brewer HB
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1813-21. PubMed ID: 9327782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The establishment of telomerase-immortalized Tangier disease cell lines indicates the existence of an apolipoprotein A-I-inducible but ABCA1-independent cholesterol efflux pathway.
    Walter M; Forsyth NR; Wright WE; Shay JW; Roth MG
    J Biol Chem; 2004 May; 279(20):20866-73. PubMed ID: 15001567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.
    Francis GA; Knopp RH; Oram JF
    J Clin Invest; 1995 Jul; 96(1):78-87. PubMed ID: 7615839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion.
    Mendez AJ
    J Lipid Res; 1997 Sep; 38(9):1807-21. PubMed ID: 9323590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects.
    Walter M; Gerdes U; Seedorf U; Assmann G
    Biochem Biophys Res Commun; 1994 Nov; 205(1):850-6. PubMed ID: 7999122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts.
    Haidar B; Denis M; Krimbou L; Marcil M; Genest J
    J Lipid Res; 2002 Dec; 43(12):2087-94. PubMed ID: 12454270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins.
    Wolfbauer G; Albers JJ; Oram JF
    Biochim Biophys Acta; 1999 Jul; 1439(1):65-76. PubMed ID: 10395966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter.
    Haidar B; Denis M; Marcil M; Krimbou L; Genest J
    J Biol Chem; 2004 Mar; 279(11):9963-9. PubMed ID: 14701824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects.
    Fobker M; Voss R; Reinecke H; Crone C; Assmann G; Walter M
    FEBS Lett; 2001 Jul; 500(3):157-62. PubMed ID: 11445077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids.
    Oram JF; Yokoyama S
    J Lipid Res; 1996 Dec; 37(12):2473-91. PubMed ID: 9017501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.
    Walter M; Reinecke H; Gerdes U; Nofer JR; Höbbel G; Seedorf U; Assmann G
    J Clin Invest; 1996 Nov; 98(10):2315-23. PubMed ID: 8941649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux.
    Utech M; Höbbel G; Rust S; Reinecke H; Assmann G; Walter M
    Biochem Biophys Res Commun; 2001 Jan; 280(1):229-36. PubMed ID: 11162504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I.
    von Eckardstein A; Chirazi A; Schuler-Lüttmann S; Walter M; Kastelein JJ; Geisel J; Real JT; Miccoli R; Noseda G; Höbbel G; Assmann G
    J Lipid Res; 1998 May; 39(5):987-98. PubMed ID: 9610765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency.
    Marcil M; Bissonnette R; Vincent J; Krimbou L; Genest J
    Circulation; 2003 Mar; 107(10):1366-71. PubMed ID: 12642355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol.
    Bielicki JK; Johnson WJ; Weinberg RB; Glick JM; Rothblat GH
    J Lipid Res; 1992 Nov; 33(11):1699-709. PubMed ID: 1464753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased cholesterol efflux from fibroblasts of a patient without Tangier disease, but with markedly reduced high density lipoprotein cholesterol levels.
    Eberhart GP; Mendez AJ; Freeman MW
    J Clin Endocrinol Metab; 1998 Mar; 83(3):836-46. PubMed ID: 9506737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients.
    Rogler G; Trümbach B; Klima B; Lackner KJ; Schmitz G
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):683-90. PubMed ID: 7749882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol.
    Oram JF; Vaughan AM; Stocker R
    J Biol Chem; 2001 Oct; 276(43):39898-902. PubMed ID: 11546785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
    Neufeld EB; Stonik JA; Demosky SJ; Knapper CL; Combs CA; Cooney A; Comly M; Dwyer N; Blanchette-Mackie J; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2004 Apr; 279(15):15571-8. PubMed ID: 14747463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.